Loading...

Home
ETF
HALO

HALO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

HALO News

Halozyme and Johnson & Johnson's Combination Therapy Approved

4d agoNASDAQ.COM

FDA Approves Halozyme and Johnson & Johnson's TECVAYLI for Multiple Myeloma

4d agoPRnewswire

FDA Approves Halozyme and Johnson & Johnson's TECVAYLI for Multiple Myeloma Treatment

4d agoNewsfilter

FDA Approves Johnson & Johnson's Tecvayli for Multiple Myeloma Treatment

4d agoseekingalpha

Halozyme Announces Upcoming Investor Conference Presentations

Feb 25 2026PRnewswire

Halozyme Reports Q4 2026 Earnings Miss, Stock Drops

Feb 18 2026seekingalpha

Halozyme Therapeutics Q4 2025 Earnings Call Highlights

Feb 18 2026seekingalpha

Halozyme Reports Strong Q4 and 2025 Revenue Growth

Feb 17 2026seekingalpha

Halozyme Therapeutics Q4 Earnings Preview

Feb 16 2026seekingalpha

Halozyme Acquires Three Biotech Startups for $1.3 Billion

Feb 15 2026Yahoo Finance

Tech Stocks Struggle While Consumer Staples Shine

Feb 04 2026Yahoo Finance

Halozyme Raises 2026 Revenue Guidance and Acquires Surf Bio

Jan 28 2026stocktwits

Halozyme Raises 2026 Financial Guidance Amid Strong Growth

Jan 28 2026Benzinga

Halozyme Raises Financial Outlook and Acquires Surf Bio for Up to $400M

Jan 28 2026seekingalpha

Halozyme Raises 2026 Financial Guidance and Acquires Surf Bio

Jan 28 2026PRnewswire

Halozyme Updates Preliminary 2025 Financial Estimates and Raises 2026 Guidance

Jan 28 2026Newsfilter